Showing 41 - 60 results of 124,667 for search '(( significant ((ns decrease) OR (mean decrease)) ) OR ( significant differences between ))', query time: 2.60s Refine Results
  1. 41
  2. 42

    Synaptopathy at IHC-SGN synapses decreases the peak of the CAP significantly, without changes to peak latency and width. by Maral Budak (6680351)

    Published 2021
    “…The latencies of the CAP peaks did not exhibit any significant difference between different populations for all sound levels.…”
  3. 43
  4. 44
  5. 45
  6. 46
  7. 47
  8. 48
  9. 49

    a-d. Difference in (a) probing depth; (b) clinical attachment level; (c) bleeding on probing, and (d) plaque index values between baseline and six months after treatment using systemic and local antibiotic treatment. **** - <i>p</i> values less than 0.001; ns – not significant. by Iva Milinkovic (22331710)

    Published 2025
    “…<p>a-d. Difference in (a) probing depth; (b) clinical attachment level; (c) bleeding on probing, and (d) plaque index values between baseline and six months after treatment using systemic and local antibiotic treatment. **** - <i>p</i> values less than 0.001; ns – not significant.…”
  10. 50
  11. 51
  12. 52

    Significant interaction (time by group) for PPTd. by Einat Kodesh (13132997)

    Published 2022
    “…<p>The measurement of pain pressure threshold (mean±standard error) on the Deltoid (PPTd) showed that responders (black solid line) demonstrated a significant decrease in PPTd following eccentric exercise. …”
  13. 53
  14. 54
  15. 55
  16. 56
  17. 57

    B2 decreases glycolytic intermediates in cells. by Craig Eyster (392633)

    Published 2025
    “…Other abbreviations: HGA, DL-hydroxyglutaric acid; PEP, phosphoenolpyruvic acid; 3-PGA, 3-phosphoglyceric acid; G3P; glyceraldehyde 3-phosphate; Data (n = 5) are shown as mean±SD. Not significant (ns): **<i>P</i> ≤ 0.01, ****<i>P</i> ≤ 0.0001by one-way ANOVA with multiple comparison of the mean of each test group to the mean of the vehicle control. …”
  18. 58
  19. 59
  20. 60

    Regenerating axons are increased by ATRA and decreased by clodronate. by Valeria De La Rosa-Reyes (6658613)

    Published 2021
    “…Compared to PBS-treated, the number of regenerating axons is doubled by ATRA treatment, decreased by 30% by clodronate, and, in the case of ATRA combined with clodronate, is not significantly different.…”